Clinical Trial

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine

Study acronym: RVF
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 11, 2021 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.
Summary
This study is to collect safety and immunogenicity data for an Rift Valley Fever (RVF) vaccine
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2018-07-24; most recent amendment 2022-07-20.
Status change: Recruiting → Completed 2022-07-20
Status change: Not Yet Recruiting → Recruiting 2018-10-09
Trial Details
NCT Number NCT03609398
Lead Sponsor U.S. Army Medical Research and Development Command
Conditions Rift Valley Fever
Enrollment 500 participants
Start Date 2018-10-04
Primary Completion 2023-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2021-02-11